Literature DB >> 11500748

Chagas' heart disease: evolutive evaluation of electrocardiographic and echocardiographic parameters in patients with the indeterminate form.

B M Ianni1, E Arteaga, C C Frimm , A C Pereira Barretto, C Mady.   

Abstract

OBJECTIVE: To identify and associate potential electrocardiographic and echocardiographic changes in patients with the indeterminate form of Chagas' disease during long-term follow-up.
METHODS: One hundred sixty patients underwent standard electrocardiography and two-dimensional guided M-mode echocardiography for left ventricular ejection fraction determination. Patients were followed up for 98.6+/-30.4 months, undergoing repeat electrocardiographic studies at 6-month intervals and echocardiographic studies at 12-month intervals.
RESULTS: Based on the electrocardiographic findings, the patients were divided into group I, 125 patients (78.6%) with normal electrocardiograms throughout follow-up, and group II, 34 patients (21.3%) who developed electrocardiographic changes. Group II was further divided into group IIA (9 patients, 5.6%) with permanent electrocardiographic changes, group IIB (14 patients, 8.8%) with transitory electrocardiographic changes, and group IIC (11 patients, 6.9%) with changes appearing only on the final electrocardiogram. Left ventricular ejection fractions remained normal in the entire population studied and did not differ among groups.
CONCLUSION: The indeterminate form of Chagas' disease clearly represents a benign condition with a favorable long-term prognosis. Although some patients develop electrocardiographic changes, left ventricular systolic function is well preserved.

Entities:  

Mesh:

Year:  2001        PMID: 11500748     DOI: 10.1590/s0066-782x2001000700006

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  10 in total

Review 1.  Cardiac involvement with parasitic infections.

Authors:  Alicia Hidron; Nicholas Vogenthaler; José I Santos-Preciado; Alfonso J Rodriguez-Morales; Carlos Franco-Paredes; Anis Rassi
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

2.  Echocardiographic parameters and survival in Chagas heart disease with severe systolic dysfunction.

Authors:  Daniela do Carmo Rassi; Marcelo Luiz Campos Vieira; Ana Lúcia Martins Arruda; Viviane Tiemi Hotta; Rogério Gomes Furtado; Danilo Teixeira Rassi; Salvador Rassi
Journal:  Arq Bras Cardiol       Date:  2014-02-10       Impact factor: 2.000

Review 3.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

4.  Dysregulation of Autonomic Nervous System in Chagas' Heart Disease Is Associated with Altered Adipocytokines Levels.

Authors:  João Marcos Barbosa-Ferreira; Charles Mady; Barbara Maria Ianni; Heno Ferreira Lopes; Felix José Alvarez Ramires; Vera Maria Cury Salemi; Cesar José Grupi; Denise Tessariol Hachul; Fábio Fernandes
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

5.  Mortality among blood donors seropositive and seronegative for Chagas disease (1996-2000) in São Paulo, Brazil: A death certificate linkage study.

Authors:  Ligia Capuani; Ana Luiza Bierrenbach; Airlane Pereira Alencar; Alfredo Mendrone; João Eduardo Ferreira; Brian Custer; Antonio Luiz P Ribeiro; Ester Cerdeira Sabino
Journal:  PLoS Negl Trop Dis       Date:  2017-05-18

6.  The Indeterminate Form of Chagas Disease.

Authors:  Victor Sarli Issa
Journal:  Arq Bras Cardiol       Date:  2018-02       Impact factor: 2.000

7.  Progression Rate from the Indeterminate Form to the Cardiac Form in Patients with Chronic Chagas Disease: Twenty-Two-Year Follow-Up in a Brazilian Urban Cohort.

Authors:  Alejandro Marcel Hasslocher-Moreno; Sergio Salles Xavier; Roberto Magalhães Saraiva; Luiz Henrique Conde Sangenis; Marcelo Teixeira de Holanda; Henrique Horta Veloso; Andrea Rodrigues da Costa; Fernanda de Souza Nogueira Sardinha Mendes; Pedro Emmanuel Alvarenga Americano do Brasil; Gilberto Marcelo Sperandio da Silva; Mauro Felippe Felix Mediano; Andrea Silvestre de Sousa
Journal:  Trop Med Infect Dis       Date:  2020-05-12

8.  Diagnostic and Prognostic Importance of Functional Capacity in the Different Evolutionary Forms of Chagas Disease.

Authors:  João Marcos Barbosa-Ferreira; Charles Mady; Fábio Fernandes
Journal:  Arq Bras Cardiol       Date:  2021-11       Impact factor: 2.000

9.  Determinants of Functional Capacity in Patients with Chagas Disease.

Authors:  Whesley Tanor Silva; Henrique Silveira Costa; Pedro Henrique Scheidt Figueiredo; Márcia Maria Oliveira Lima; Vanessa Pereira Lima; Fábio Silva Martins da Costa; Matheus Ribeiro Ávila; Vanessa Amaral Mendonça; Ana Cristina Rodrigues Lacerda; Maria Carmo Pereira Nunes; Manoel Otávio Costa Rocha
Journal:  Arq Bras Cardiol       Date:  2021-11       Impact factor: 2.000

10.  Evaluation of Parasiticide Treatment with Benznidazol in the Electrocardiographic, Clinical, and Serological Evolution of Chagas Disease.

Authors:  Abilio Augusto Fragata-Filho; Francisco Faustino França; Claudia da Silva Fragata; Angela Maria Lourenço; Cristiane Castro Faccini; Cristiane Aparecida de Jesus Costa
Journal:  PLoS Negl Trop Dis       Date:  2016-03-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.